Truvestments Capital’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64K | Hold |
2,458
| – | – | ﹤0.01% | 777 |
|
|
2025
Q1 | $6.29K | Hold |
2,458
| – | – | ﹤0.01% | 727 |
|
|
2024
Q4 | $4.62K | Hold |
2,458
| – | – | ﹤0.01% | 709 |
|
|
2024
Q3 | $2.51K | Buy |
+2,458
| New | +$2.51K | ﹤0.01% | 770 |
|
|
2024
Q2 | – | Sell |
-3,880
| Closed | -$4.89K | – | 554 |
|
|
2024
Q1 | $4.89K | Hold |
3,880
| – | – | ﹤0.01% | 555 |
|
|
2023
Q4 | $6.91K | Hold |
3,880
| – | – | ﹤0.01% | 554 |
|
|
2023
Q3 | $6.44K | Hold |
3,880
| – | – | ﹤0.01% | 486 |
|
|
2023
Q2 | $7.76K | Hold |
3,880
| – | – | ﹤0.01% | 475 |
|
|
2023
Q1 | $8.15K | Buy |
+3,880
| New | +$8.15K | ﹤0.01% | 455 |
|